Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis

Reduced levels of the autophagy protein p62 (SQSTM1) differentiated Lewy body dementias from Alzheimer's disease (AD) across multiple brain regions. Dementia with Lewy bodies (DLB) was distinguished from both AD and Parkinson's disease dementia (PDD) by altered TRIM33 and cysteine/glutamate transporter (SLC7A11) levels across brain regions. Key mitochondrial oxidative phosphorylation proteins (e.g., COX7A2, TOMM40L, NDUFV1), and synaptic proteins (e.g., GABRB3, GABRB2, GLUA3, GLUA4, SNAP47, dynamin1) were more abundant in preserved cognitive states. Extracellular matrix proteins and members of the complement system (decorin, biglycan, C4A, C4B) showed a strong positive correlation with cognitive decline.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-23
DOI
https://doi.org/10.1002/alz.14375
Citations
11
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
3.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis

Per Nilsson, Clive Ballard, Janne Lehtiö, Paul T. Francis et al.
11 citations
Alzheimer s & Dementia
Alzheimer's disease research and treatments
3.59
article

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis

Per Nilsson, Clive Ballard, Janne Lehtiö, Paul T. Francis, Dag Aarsland, Rui M. Branca, Anna Canal-García, Erika Bereczki, Bengt Winblad, Joana B. Pereira
article en
11 citations

Abstract

Reduced levels of the autophagy protein p62 (SQSTM1) differentiated Lewy body dementias from Alzheimer's disease (AD) across multiple brain regions. Dementia with Lewy bodies (DLB) was distinguished from both AD and Parkinson's disease dementia (PDD) by altered TRIM33 and cysteine/glutamate transporter (SLC7A11) levels across brain regions. Key mitochondrial oxidative phosphorylation proteins (e.g., COX7A2, TOMM40L, NDUFV1), and synaptic proteins (e.g., GABRB3, GABRB2, GLUA3, GLUA4, SNAP47, dynamin1) were more abundant in preserved cognitive states. Extracellular matrix proteins and members of the complement system (decorin, biglycan, C4A, C4B) showed a strong positive correlation with cognitive decline.

Alzheimer s & DementiaVol. 21(1)
King's College London (GB), University of Exeter (GB), Stavanger University Hospital (NO), Science for Life Laboratory (SE), Karolinska Institutet (SE)
Gun och Bertil Stohnes Stiftelse, Loo och Hans Ostermans Stiftelse för Medicinsk Forskning, Stiftelsen för Gamla Tjänarinnor, Magnus Bergvalls Stiftelse, Stiftelsen Längmanska Kulturfonden, Demensfonden
Openalex Percentile: Top 6%
Alzheimer's disease research and treatments
3.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.